Department of Oral Science, University of Bologna, Italy.
Int J Oral Maxillofac Surg. 2011 May;40(5):556-8. doi: 10.1016/j.ijom.2010.11.008. Epub 2010 Dec 15.
The development of secondary malignancies is a potential long-term complication after haematopoietic stem cell transplantation (HSCT). In particular, a higher incidence of oral squamous cell carcinoma (OSCC) has been reported in patients experiencing chronic graft versus host disease (cGvHD) secondary to HSCT. This report describes the development of two synchronous SCC of the buccal mucosa in a young female patient treated with HSCT for beta thalassemia major. She had undergone HSCT at the age of 9 years and developed oral GvHD 6 months after transplant. 17 years after HSCT she developed two synchronous carcinomatous lesions on the tongue and floor of the mouth. The current case highlights the association between oral cGvHD and OSCC, and the possible development of OSCC in young patients even many years after HSCT. This evidence suggests closer follow-up for all patients treated with HSCT who developed cGvHD, and more effective strategies to prevent and treat cGvHD.
继发性恶性肿瘤是造血干细胞移植(HSCT)后潜在的长期并发症。特别是,有报道称,在因 HSCT 而发生慢性移植物抗宿主病(cGvHD)的患者中,口腔鳞状细胞癌(OSCC)的发病率更高。本报告描述了一名年轻女性患者在接受 HSCT 治疗重型β地中海贫血后发生的两处颊黏膜同步 SCC。她在 9 岁时接受了 HSCT,并在移植后 6 个月发生口腔 GvHD。17 年后,她的舌和口底出现两处同步癌性病变。本病例强调了口腔 cGvHD 与 OSCC 之间的关联,以及即使在 HSCT 多年后,年轻患者也可能发生 OSCC。这一证据表明,所有接受 HSCT 并发生 cGvHD 的患者都需要进行更密切的随访,并制定更有效的策略来预防和治疗 cGvHD。